Literature DB >> 12626641

Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line.

Lingke Zhao1, Yen-Ping Kuo, Andrew A George, Jian-Hong Peng, Madhuri Singh Purandare, Katherine M Schroeder, Ronald J Lukas, Jie Wu.   

Abstract

alpha 7-Nicotinic acetylcholine receptors (alpha 7-nAChRs) are broadly distributed in the central nervous system, where they play important roles in chemical and electrical signaling, and perhaps in neurite outgrowth, synaptic plasticity, and neuronal death/survival. To help elucidate their normal and pathophysiological roles, we have heterologously expressed human alpha 7-nAChR in transfected SH-EP1 human epithelial cells. Reverse transcription-polymerase chain reaction and mRNA fluorescence in situ hybridization analyses demonstrate expression of human alpha 7 subunits as messenger RNA. Patch-clamp recordings exploiting a novel strategy to prevent functional rundown of whole-cell peak current responses to repeated acute challenges with nicotinic agonists show successful expression of functional alpha 7-nAChR that mediate inward currents characterized by rapid phases of activation and inactivation. Concentration-response curves show that nicotine, acetylcholine, and choline are efficacious agonists at human alpha 7-nAChRs. Current-voltage relationships show inward rectification for agonist-induced currents. Human alpha 7-nAChRs exhibit some sensitivity to alpha 7-nAChR antagonists alpha-bungarotoxin (Bgt) or methyllycaconitine (MLA) when applied coincidentally with agonist, but much higher affinity block occurs when cells and alpha 7-nAChRs are pre-exposed to antagonists for 2 min before challenge with agonist. Both Bgt and MLA are competitive inhibitors of alpha 7-nAChR function. Whole-cell current peak amplitudes and half-times for inactivation of alpha 7-nAChR functional responses to nicotine are dramatically reduced in the absence of extracellular Ca2+, suggestive of high Ca2+ permeability of the alpha 7-nAChR channel. Thus, heterologously expressed human alpha 7-nAChR in mammalian cells have properties of native alpha 7-nAChR or of alpha 7-nAChR heterologously expressed in other systems and serve as excellent models for studies of molecular bases of alpha 7-nAChR function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626641     DOI: 10.1124/jpet.103.048777

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Activation of heteroliganded mouse muscle nicotinic receptors.

Authors:  Gustav Akk; Lorin S Milescu; Manfred Heckmann
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

2.  A novel method for patch-clamp automation.

Authors:  D Vasilyev; T Merrill; A Iwanow; J Dunlop; M Bowlby
Journal:  Pflugers Arch       Date:  2006-04-05       Impact factor: 3.657

3.  The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells.

Authors:  Juan Arredondo; Alex I Chernyavsky; Sergei A Grando
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-12       Impact factor: 4.553

4.  Identification of domains influencing assembly and ion channel properties in alpha 7 nicotinic receptor and 5-HT3 receptor subunit chimaeras.

Authors:  V J Gee; S Kracun; S T Cooper; A J Gibb; N S Millar
Journal:  Br J Pharmacol       Date:  2007-08-27       Impact factor: 8.739

5.  Pharmacological and functional comparisons of α6/α3β2β3-nAChRs and α4β2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line.

Authors:  De-Jie Chen; Fen-Fei Gao; Xiao-Kuang Ma; Gang-Gang Shi; Yuan-Bing Huang; Quang-Xi Su; Sterling Sudweeks; Ming Gao; Turner Dharshaun; Jason Brek Eaton; Yong-Chang Chang; J Michael Mcintosh; Ronald J Lukas; Paul Whiteaker; Scott C Steffensen; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

6.  Targeting cholinesterase inhibitor poisoning with a novel blocker against both nicotinic and muscarinic receptors.

Authors:  Wangqian Luo; Xulin Ge; Wenyu Cui; Hai Wang
Journal:  Neurotox Res       Date:  2009-10-15       Impact factor: 3.911

7.  Alpha6-containing nicotinic acetylcholine receptor is a highly sensitive target of alcohol.

Authors:  Fenfei Gao; Dejie Chen; Xiaokuang Ma; Sterling Sudweeks; Jordan T Yorgason; Ming Gao; Dharshaun Turner; Jason Brek Eaton; J Michael McIntosh; Ronald J Lukas; Paul Whiteaker; Yongchang Chang; Scott C Steffensen; Jie Wu
Journal:  Neuropharmacology       Date:  2019-01-30       Impact factor: 5.250

8.  Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.

Authors:  Yingxian Xiao; Galya R Abdrakhmanova; Maryna Baydyuk; Susan Hernandez; Kenneth J Kellar
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

9.  Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells.

Authors:  Paraskevi Krashia; Mirko Moroni; Steven Broadbent; Giovanna Hofmann; Sebastian Kracun; Marco Beato; Paul J Groot-Kormelink; Lucia G Sivilotti
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

10.  Distinctive nicotinic acetylcholine receptor functional phenotypes of rat ventral tegmental area dopaminergic neurons.

Authors:  Kechun Yang; Jun Hu; Linda Lucero; Qiang Liu; Chao Zheng; Xuechu Zhen; Guozhang Jin; Ronald J Lukas; Jie Wu
Journal:  J Physiol       Date:  2008-12-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.